Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is unchanged from the same period last year. The company reported quarterly sales of $76.000 thousand which missed the analyst consensus estimate of $136.917 thousand by 44.49 percent. This is a 77.78 percent decrease over sales of $342.000 thousand the same period last year.